Status | Study |
NOT_YET_RECRUITING |
Study Name: PheCheck Feasibility Study Condition: Phenylketonurias Date: 2023-08-10 Interventions: 1 fingerstick specimen collected at each study visit |
RECRUITING |
Study Name: Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU. Condition: Phenylketonurias Date: 2023-03-24 Interventions: PKU GOLIKE is a food for special medicinal purposes (FSMP) for the dietary management of PKU. |
ACTIVE_NOT_RECRUITING |
Study Name: Additional Dietary Large Neutral Amino Acids (LNAA) for Improved Symptoms in Adult Classical Phenylktonuria (PKU) Condition: Phenylketonurias Date: 2021-12-13 Interventions: PreKUnil� LNAA Medical Food for PKU is a commercially available active LNAA treatment product for PKU.PreKUnil� inactive LNAA is a customized pl |
Not yet recruiting |
Study Name: MRI Spectroscopy and Neuropsychological Functioning in Phenylketonuria Condition: Phenylketonuria Date: 2017-03-22 |
Not yet recruiting |
Study Name: Simplified Diet Approach in Phenylketonuria Condition: Phenylketonuria Date: 2015-09-17 Interventions: Behavioral: Dietary Protein Counting and Free Fruits and Vegetables Subjects will be educated on new sim |
Terminated |
Study Name: Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria Condition: Phenylketonuria Date: 2013-10-31 Interventions: Drug: Sapropterin Sapropterin |
Active, not recruiting |
Study Name: Kuvan®'s Effect on the Cognition of Children With Phenylketonuria Condition: Phenylketonuria Date: 2013-10-16 Interventions: Drug: Kuvan® Kuvan® oral soluble tablet will be administered once daily along with Phenylalani |
Completed |
Study Name: Protein Requirements in Children With Phenylketonuria (PKU) Condition: Phenylketonuria Date: 2013-10-16 Interventions: Dietary Supplement: Protein intake Oral consumption of eig |
Completed |
Study Name: The Brain, Neurological Features and Neuropsychological Functioning in Adults With Phenylketonuria: A Pilot Study Condition: Phenylketonuria Date: 2013-08-05 Interventions: Other: MRI |
Completed |
Study Name: Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With Phenylketonuria Condition: Phenylketonuria Date: 2012-11-19 Interventions: Drug: Kuvan® Kuvan® (sapropterin dihydrochloride) will be administered orally at a dose of 20 |